(January 17 03:41) Forbes.com
A California biopharmaceutical company has announced positive results from a clinical trial testing MDMA as a treatment for post-traumatic stress disorder, bolstering its efforts to gain federal approval for the therapeutic use of the psychedelic drug also known as ecstasy.
You can find the original article
here